Focus: Machine Solutions is a private device manufacturing company headquartered in Flagstaff, Arizona, operating in the biotechnology segment with a focused product portfolio.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
2 recent layoff filings (12 mo) — 134 affected
Source: state DOL filings via Big Local News
No open roles listed right now. Follow Machine Solutions to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Sole marketed product currently at peak commercial stage, suggesting established market presence but limited portfolio diversification.
Help build intelligence for Machine Solutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Machine Solutions's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Machine Solutions Inc. Acquires Megadale, Adds Ireland Site for Intec Automation - Via Ritzau
Machine Solutions Inc. Acquires Megadale, Adds Ireland Site for Intec Automation Via Ritzau
8-K Filing: JBT MAREL Corp (JBTM) (CIK 0001433660) — EX-99.1
EX-99.1
Marchesini with pharmaceutical laboratory and AI innovations at CPhI 2023 - packaging journal
Marchesini with pharmaceutical laboratory and AI innovations at CPhI 2023 packaging journal
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Source: state DOL filings, aggregated via Big Local News
No regulatory or workforce reduction signals detected, but lack of comprehensive data limits full risk assessment.